Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.
Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.
复制标题
肿瘤坏死因子样弱凋亡诱导剂和成纤维细胞生长因子诱导剂14在多发性肌炎和皮肌炎患者中的表达
DOI:
10.1186/ar4454
复制
发表时间:
2014-01-27
影响因子:
4.9
通讯作者:
Wang GC
中科院分区:
文献类型:
--
作者:
Peng QL;Shu XM;Tian XL;Lu X;Wang GC
The aim of this study was to investigate the expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) in patients with polymyositis (PM) and dermatomyositis (DM), and their relation to clinical manifestations. Serum levels of TWEAK were detected in 98 PM/DM patients and 37 healthy controls by using the ELISA method. Total RNA isolated from fresh-frozen muscle tissue samples of 36 PM/DM patients and 10 healthy controls were used for analyzing the mRNA levels of TWEAK and Fn14 by quantitative reverse transcription polymerase chain reaction (RT-PCR). Immunofluorescence staining of TWEAK and Fn14 was conducted on muscle biopsy specimens from 23 PM/DM patients and seven healthy controls. Serum levels of TWEAK were significantly decreased in the PM/DM patients compared to those in the healthy controls (P < 0.001), and serum TWEAK levels negatively correlated with serum CD163 levels in PM/DM patients (r = -0.49, P < 0.001). The expression of Fn14 mRNA was significantly increased in the muscle tissue of PM/DM patients than in the muscle tissue of healthy controls (P < 0.01), whereas the expression of TWEAK mRNA in PM/DM patients was not statistically different from that of the healthy controls (P > 0.05). Fn14 mRNA levels in muscle tissue positively correlated with muscle disease activity (r = 0.512, P < 0.01). Patients with oropharyngeal dysphagia had significantly higher Fn14 mRNA levels than patients without oropharyngeal dysphagia (P < 0.05). The results of immunofluorescence staining showed that 19 out of 23 PM/DM patients were TWEAK-positive, and 20 out of 23 PM/DM patients were Fn14-positive. No detectable expressions of TWEAK or Fn14 were observed in the healthy controls. TWEAK-Fn14 axis may be involved in the pathogenesis of PM/DM. Further understanding of TWEAK-Fn14 function in PM/DM may help to define therapeutic targets for PM/DM.
登录
查看更多内容
DOI:
10.1097/mco.0b013e328351c3fc
发表时间:
2012-05
影响因子:
3.1
作者:
Kumar A;Bhatnagar S;Paul PK
通讯作者:
Paul PK
DOI:
10.4049/jimmunol.0803357
发表时间:
2009-02-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kumar M;Makonchuk DY;Li H;Mittal A;Kumar A
通讯作者:
Kumar A
影响因子:
4.4
作者:
Bover, Laura C.;Cardo-Vila, Marina;Pasqualini, Renata
通讯作者:
Pasqualini, Renata
影响因子:
5.1
作者:
Liu Zhi-Chun;Zhou Qiao-Ling;Tang Rong
通讯作者:
Tang Rong
影响因子:
5.5
作者:
Isenberg, DA;Allen, E;Miller, F
通讯作者:
Miller, F